Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $dtil

Precision BioSciences ($DTIL) announces positive Phase X data for its Hepatitis B program and advancements in its Duchenne Muscular Dystrophy program. The company's ARCUS gene editing technology is being praised for its superiority over CRISPR.

### About $dtil
Precision BioSciences is a biotechnology company focused on developing gene-based therapies.  

### Insights
- $dtil sentiment is up XXXXXX% from the previous week.
- $dtil posts created is up XX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$dtil/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$dtil/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX +2.10%  
X Year: XXXXXXXXX +195%  
1-Year High: XXXXXXX on 2025-06-25  
1-Year Low: XX on 2025-09-07  

Engagements by network (24h):
Reddit: XX
X: XXX

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$dtil/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$dtil/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: XX  
X Week: XX -XXXX%  
X Month: XXX -XXXX%  
X Months: XXXXX +353%  
X Year: XXXXX +752%  
1-Year High: XXXXX on 2025-06-25  
1-Year Low: X on 2025-09-07  

Mentions by network (24h):
Reddit: XX
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$dtil/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$dtil/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $dtil in the last XX hours which is no change from in the previous XX hours
Daily Average: XX  
X Week: XX -XXXX%  
X Month: XXX +10%  
X Months: XXXXX +659%  
X Year: XXXXX +942%  
1-Year High: XXX on 2025-06-25  
1-Year Low: X on 2025-09-07  

The most influential creators that mention $dtil in the last XX hours

| Creator                                                       | Rank | Followers | Posts | Engagements |
| -------                                                       | ---- | --------- | ----- | ----------- |
| [@Fit_Presentation1595](/creator/reddit/Fit_Presentation1595) | X    |           | X     | XX          |
| [@Soeren_Berlin](/creator/twitter/Soeren_Berlin)              | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$dtil/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$dtil/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$dtil/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% +83%  
X Month: XXX% no change  
X Months: XXX% no change  
X Year: XXX% +10%  
1-Year High: XXX% on 2024-12-12  
1-Year Low: XX% on 2025-12-02  

Most Supportive Themes:
- ARCUS Technology Superiority: (30%) Precision BioSciences' ARCUS gene editing technology is highlighted as superior to CRISPR due to its precision, smaller size, and lower dosing requirements, potentially offering a better safety profile.
- Hepatitis B (HBV) Program Progress: (25%) Positive updates on the PBGENE-HBV program, including early Phase X data showing reductions in surface antigen levels and acceptance for oral presentation at AASLD The Liver Meeting, indicate significant progress towards a potential cure.
- Duchenne Muscular Dystrophy (DMD) Program Advancements: (20%) The PBGENE-DMD program is seen as transformative, with preclinical updates showing durable improvements in muscle function and the potential for a one-time curative treatment. The program has received rare pediatric disease designation and is on track for IND/CTA filing.
- Financial Health and Runway: (15%) The company's cash runway extending to late 2027 and a relatively small market cap compared to its potential are viewed as de-risking factors and attractive investment opportunities.
  
Most Critical Themes:
- Novartis Partnership Termination: (5%) The termination of the Novartis agreement, while not a major factor for some, was noted as being hidden in a 10-K filing, raising concerns about management's transparency.
- Comparison to NTLA Setbacks: (5%) While the setbacks faced by NTLA are seen as a positive for DTIL by highlighting ARCUS's advantages, the general volatility and safety concerns in the gene editing space can create broader market apprehension.
  

### Top $dtil Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$DTIL ECU-506 data Update on ECUR-506 Data from Hot Topics in Neonatology 2025. The poster presentation at the Hot Topics in Neonatology conference today (December X 2025) included initial findings from the first four neonates enrolled in the Phase 1/2 OTC-HOPE trial"  
[X Link](https://x.com/TJK_RBLTG/status/1998428499783094698) [@TJK_RBLTG](/creator/x/TJK_RBLTG) 2025-12-09T16:24Z X followers, XXX engagements


"$MVST $DATS $NVDA $TSLA $AAPL $GME $AMC $DJT $BCT.X $ETH.X $DOGE.X $SHIB.X $SPY $XRP.X $FFIE $HOLO $MLGO $TNXP $SAVA $CDT $VRME $DRCT $SANA $BAER $WKEY $HOTH $HCWC $INTZ $ZVSA $BNRG $VMAR $DTIL $HCWC $MSW $SENS $GRNQ $KAVL $GCTK $TRAW $SAGE"  
[X Link](https://x.com/BigMonty69/status/1998370461093417118) [@BigMonty69](/creator/x/BigMonty69) 2025-12-09T12:33Z XXX followers, XXX engagements


""See these #healthcare management teams present live and submit your questions during Q&A. $CRDF $DRTS $DTIL $EVAX $IRIX $NNOX $PRE $SBC $SINT $TRNLY All investors are welcome to join free of charge:"  
[X Link](https://x.com/SidotiResearch/status/1998127987653259484) [@SidotiResearch](/creator/x/SidotiResearch) 2025-12-08T20:30Z XXX followers, XXX engagements


"AI watchlist for Long-Term Portfolio: 1- $NVDA 2- $PLTR 3- $AMD 4- $SNOW 5- $AI 6- $APP 7- $CRNC 8- $INOD 9- $SOUN 10- $MU $DATS $INTZ $VMAR $DRCT $BNRG $NRXP $WBA $DTIL $ANNA $MVST $ATIF $CEG $JYD $AMST $GDTC $AMPX $AXGN $ETON $MASS $SVV $CING $SERV $WOK $ZCAR $SONM"  
[X Link](https://x.com/SMALLCAPSAXIS/status/1998061493187965034) [@SMALLCAPSAXIS](/creator/x/SMALLCAPSAXIS) 2025-12-08T16:05Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$dtil

Precision BioSciences ($DTIL) announces positive Phase X data for its Hepatitis B program and advancements in its Duchenne Muscular Dystrophy program. The company's ARCUS gene editing technology is being praised for its superiority over CRISPR.

About $dtil

Precision BioSciences is a biotechnology company focused on developing gene-based therapies.

Insights

  • $dtil sentiment is up XXXXXX% from the previous week.
  • $dtil posts created is up XX% from the previous week.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX +2.10%
X Year: XXXXXXXXX +195%
1-Year High: XXXXXXX on 2025-06-25
1-Year Low: XX on 2025-09-07

Engagements by network (24h): Reddit: XX X: XXX

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XXXX%
X Month: XXX -XXXX%
X Months: XXXXX +353%
X Year: XXXXX +752%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2025-09-07

Mentions by network (24h): Reddit: XX X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $dtil in the last XX hours which is no change from in the previous XX hours Daily Average: XX
X Week: XX -XXXX%
X Month: XXX +10%
X Months: XXXXX +659%
X Year: XXXXX +942%
1-Year High: XXX on 2025-06-25
1-Year Low: X on 2025-09-07

The most influential creators that mention $dtil in the last XX hours

Creator Rank Followers Posts Engagements
@Fit_Presentation1595 X X XX
@Soeren_Berlin X XXXXX X XX

View More

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% +83%
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% +10%
1-Year High: XXX% on 2024-12-12
1-Year Low: XX% on 2025-12-02

Most Supportive Themes:

  • ARCUS Technology Superiority: (30%) Precision BioSciences' ARCUS gene editing technology is highlighted as superior to CRISPR due to its precision, smaller size, and lower dosing requirements, potentially offering a better safety profile.
  • Hepatitis B (HBV) Program Progress: (25%) Positive updates on the PBGENE-HBV program, including early Phase X data showing reductions in surface antigen levels and acceptance for oral presentation at AASLD The Liver Meeting, indicate significant progress towards a potential cure.
  • Duchenne Muscular Dystrophy (DMD) Program Advancements: (20%) The PBGENE-DMD program is seen as transformative, with preclinical updates showing durable improvements in muscle function and the potential for a one-time curative treatment. The program has received rare pediatric disease designation and is on track for IND/CTA filing.
  • Financial Health and Runway: (15%) The company's cash runway extending to late 2027 and a relatively small market cap compared to its potential are viewed as de-risking factors and attractive investment opportunities.

Most Critical Themes:

  • Novartis Partnership Termination: (5%) The termination of the Novartis agreement, while not a major factor for some, was noted as being hidden in a 10-K filing, raising concerns about management's transparency.
  • Comparison to NTLA Setbacks: (5%) While the setbacks faced by NTLA are seen as a positive for DTIL by highlighting ARCUS's advantages, the general volatility and safety concerns in the gene editing space can create broader market apprehension.

Top $dtil Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$DTIL ECU-506 data Update on ECUR-506 Data from Hot Topics in Neonatology 2025. The poster presentation at the Hot Topics in Neonatology conference today (December X 2025) included initial findings from the first four neonates enrolled in the Phase 1/2 OTC-HOPE trial"
X Link @TJK_RBLTG 2025-12-09T16:24Z X followers, XXX engagements

"$MVST $DATS $NVDA $TSLA $AAPL $GME $AMC $DJT $BCT.X $ETH.X $DOGE.X $SHIB.X $SPY $XRP.X $FFIE $HOLO $MLGO $TNXP $SAVA $CDT $VRME $DRCT $SANA $BAER $WKEY $HOTH $HCWC $INTZ $ZVSA $BNRG $VMAR $DTIL $HCWC $MSW $SENS $GRNQ $KAVL $GCTK $TRAW $SAGE"
X Link @BigMonty69 2025-12-09T12:33Z XXX followers, XXX engagements

""See these #healthcare management teams present live and submit your questions during Q&A. $CRDF $DRTS $DTIL $EVAX $IRIX $NNOX $PRE $SBC $SINT $TRNLY All investors are welcome to join free of charge:"
X Link @SidotiResearch 2025-12-08T20:30Z XXX followers, XXX engagements

"AI watchlist for Long-Term Portfolio: 1- $NVDA 2- $PLTR 3- $AMD 4- $SNOW 5- $AI 6- $APP 7- $CRNC 8- $INOD 9- $SOUN 10- $MU $DATS $INTZ $VMAR $DRCT $BNRG $NRXP $WBA $DTIL $ANNA $MVST $ATIF $CEG $JYD $AMST $GDTC $AMPX $AXGN $ETON $MASS $SVV $CING $SERV $WOK $ZCAR $SONM"
X Link @SMALLCAPSAXIS 2025-12-08T16:05Z XXX followers, XXX engagements

$dtil
/topic/$dtil